-Continued from page 145 the results into a single point estimate with confidence intervals for both beneficial and adverse effects.
For example, the meta-analysis of 16 RCTs2 on glycaemic control showed a significant reduction in progression of retinopathy with near normal glycaemic control over 2-5 years. This finding was summarised as an odds ratio of 0.49 with 95 per cent confidence interval of 0.28-0.85 (p=O.Oll)2.
Where results cannot be combined to quantify the strength of the evidence, the rea.son for this should be explained and the results of each study should be presented separately.
Standardised expression of the evidence
Evidence should be incorporated in guidelines in a standardised form. For example, the evidence for the diabetes guidelines includes: a summary statement of the results of studies which contributed evidence; a brief description of the search strategy used in identifying the relevant literature; a statement on the quality of the evidence, both from epidemiological and content-based perspectives; the assessed benefits and adverse effects; a conclusion, with recommendations for future research if needed; and references.
CONCLUSION
The eight steps described above make up a systematic method for incorporating evidence into guidelines for the clinical management of diabetes. This method can be applied to other content areas. By making the method explicit, the quality of evidence for diabetes guidelines can be assessed. For the guidelines to reflect current evidence, ongoing review is necessary. The total number of patients waiting more than 12 months fell by 72 per cent to 637. The number of patients waiting 6-12 months fell by 67 per cent to 2,132. The reduction by about 6,000 patients waiting longer than six months has been one of the most significant effects of the Program (Table 4) . Expected waiting time has diminished by three weeks to 33 days. This is a reduction of more than 60 per cent on the March figure, and is the lowest expected waiting time for elective surgery since record collection began in 1989. The average time on list has declined by more than five weeks to 2.3 months (Table 5) .
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Elective surgery admissions between April and November 1995 increased by almost 20,000 or 11.6 per cent over the corresponding period in 1994. This is likely to be an underestimate because, in mid-1994, a large number of medical procedures, such as endoscopies and chemotherapy, were erroneously being coded as surgery.
The number of Tjrgency 4 patients increased consistently from the quarter ending on September 30, 1994 to the quarter ending on September 30, 1995 (five quarters). In the quarter ending on September 30, 1995 there were 9,527 Urgency 4 elective surgery patients, an increase of almost 1,400 over the quarter ending on June 30, 1995. This was art increase of almost 1,900 over the quarter ending on March 31, 1995 (Table 6 ). the management of hospital waiting lists. The Waiting List Reduction Program has provided an impetus for this.
COMMENTS
As the Program nears its target of a 50 per cent reduction in elective surgery waiting lists, planning is being directed towards policy on the management of waiting lists and associated incentives. Best practice in the management of elective patients is a key issue for consideration. Future directions will include development and application of appropriate benchmarks to enable monitoring of the management of elective patients (both medical and surgical) and to provide incentives for continuous improvement in this management. 
